comparemela.com

Latest Breaking News On - Johan neyts - Page 4 : comparemela.com

KU Leuven drug discovery unit involved in development of COVID-19 treatment

 Aligos Therapeutics (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that it has selected ALG-097558, a broad spectrum coronavirus protease inhibitor, as its drug candidate to move forward into development.

Why you need to get a COVID booster shot

vimarsana © 2020. All Rights Reserved.